Association of plasma triglyceride-rich lipoprotein remnants with coronary atherosclerosis in cases of sudden cardiac death

Atherosclerosis

Volumn 142, Issue 2, 1999, Pages 309-315

  Takeichi, Sanae ^a   Yukawa, Nobuhiro ^a   Nakajima, Yasuhiro ^a   Osawa, Motoki ^a   Saito, Takeshi ^a   Seto, Yoshihisa ^a   Nakano, Takamitsu ^b   Saniabadi, Abby R ^b   Adachi, Masakazu ^b   Wang, Tao ^c   Nakajima, Katsuyuki ^c  

^a TOKAI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b JAPAN IMMUNORESEARCH LABORATORIES   (Japan)

^c Otsuka America Pharmaceutical   (United States)

Author keywords

Coronary atherosclerosis; LDL cholesterol; Lipoprotein remnants; RLP cholesterol; Sudden cardiac death

Indexed keywords

APOLIPOPROTEIN B; APOLIPOPROTEIN C3; APOLIPOPROTEIN E; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPOPROTEIN; LIPOPROTEIN A; LOW DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN RECEPTOR; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; AGED; AORTA ATHEROSCLEROSIS; ARTICLE; CORONARY ARTERY ATHEROSCLEROSIS; DISEASE SEVERITY; FEMALE; HUMAN; HUMAN TISSUE; HYPERCHOLESTEROLEMIA; HYPERLIPOPROTEINEMIA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK FACTOR; SUDDEN DEATH;

ADULT; AGED; APOLIPOPROTEINS; BIOLOGICAL MARKERS; CHOLESTEROL; CHOLESTEROL, HDL; CHOLESTEROL, LDL; CHOLESTEROL, VLDL; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CORONARY ARTERIOSCLEROSIS; DEATH, SUDDEN, CARDIAC; FEMALE; HUMANS; LIPOPROTEIN(A); LIPOPROTEINS; MALE; MIDDLE AGED; NEPHELOMETRY AND TURBIDIMETRY; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; TRIGLYCERIDES;

EID: 20244385536     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0021-9150(98)00246-9     Document Type: Article

References (28)

1. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Summary of the second report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel II). J Am Med Assoc 1993; 269: 3015-23.
2. NIH Consensus Development Panel on Triglyceride, High-density Lipoprotein, and Coronary Heart Disease. Triglyceride, high-density lipoprotein, and coronary heart disease. J Am Med Assoc 1993; 269: 505-10.
3. Hamsten A. Hypertriglyceridaemia, triglyceride-rich lipoproteins and coronary heart disease. Bailliére's. Clin. Endocrinol. Metab. 4:1990;895-922.
4. Hokanson J.E., Austin M.A. Plasma triglyceride level is a risk factor for cardiovascular disease independent of high-density lipoprotein cholesterol level: a meta-analysis of population-based prospective studies. J. Cardiovasc. Risk. 3:1996;213-219.
5. Hiserodt J.C., Perper J.A., Koehler S.A., Orchard T.J. A comparison of blood lipid and lipoprotein values in young adults who die suddenly and unexpectedly from atherosclerotic coronary artery disease with other noncardiac deaths. Am. J. Forensic. Med. Pathol. 16:1995;101-106.
6. Takeichi S., Nakajima Y., Osawa M. et al. The possible role of remnant-like particles as a risk factor for sudden cardiac death. Int. J. Legal Med. 110:1997;213-219.
7. Phillips N.R., Waters D., Havel R.J. Plasma lipoproteins and progression of coronary artery disease evaluated by angiography and clinical events. Circulation. 88:1993;2762-2770.
8. Karpe F., Hamsten A. Postprandial lipoprotein metabolism and atherosclerosis. Curr. Opin. Lipidol. 6:1995;123-129.
9. Alaupovic P., Mack W.J., Knight-Gibson C., Hodis H.N. The role of triglyceride-rich lipoprotein families in the progression of atherosclerotic lesions as determined by sequential coronary angiography from a controlled clinical trial. Arterioscler. Thromb. Vasc. Biol. 17:1997;715-722.
10. Nakajima K., Saito T., Tamura A. et al. A new approach for the detection of type III hyperlipoproteinemia by RLP-cholesterol assay. J. Atheroscl. Thromb. 1:1994;30-36.
11. Campos E., Nakajima K., Tanaka A., Havel R.J. Properties of an apolipoprotein E-enriched fraction of triglyceride-rich lipoproteins isolated from human blood plasma with a monoclonal antibody to apolipoprotein B-100. J. Lipid Res. 33:1992;369-380.
12. Nakajima K., Saito T., Tamura A. et al. Cholesterol in remnant-like lipoproteins in human serum using monoclonal anti apo B-100 and anti apo A-I immunoaffinity mixed gels. Clin. Chim. Acta. 223:1993;53-71.
13. Nakajima K., Okazaki M., Tanaka A. et al. Separation and determination of remnant-like particles in human serum using monoclonal antibodies to apo B-100 and apo A-I. J. Clin. Ligand Assay. 19:1996;177-183.
14. Tomono S., Kawazu S., Kato N. et al. Uptake of remnant like particles (RLP) in diabetic patients from mouse peritoneal macrophages. J. Atheroscler. Thromb. 1:1994;98-102.
15. Knöfler R., Nakano T., Nakajima K. et al. Remnant-like lipoproteins stimulate whole blood platelet aggregation in vitro. Thromb. Res. 78:1995;161-171.
16. Saniabadi A.R., Umemura K., Shimoyama M. et al. Aggregation of human blood platelets by remnant like lipoprotein particles of plasma chylomicrons and very low density lipoproteins. Thromb. Haemost. 77:1997;996-1001.
17. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 1993; 362: 801-9.
18. Takeichi S., Wakasugi C., Shikata I. Fluidity of cadaveric blood after sudden death: part I Postmortem fibrinolysis and plasma catecholamine level. Am. J. Forensic Med. Pathol. 5:1984;223-227.
19. Takeichi S., Wakasugi C., Shikata I. Fluidity of cadaveric blood after sudden death: part II Mechanism of release of plasminogen activator from blood vessels. Am. J. Forensic. Med. Pathol. 6:1985;25-29.
20. Takeichi S., Tokunaga I., Hayakumo K., Maeiwa M. Fluidity of cadaveric blood after sudden death: part III Acid-base balance and fibrinolysis. Am. J. Forensic. Med. Pathol. 7:1986;35-38.
21. Hara I., Okazaki M. High-performance liquid chromatography of serum lipoproteins. Methods Enzymol. 129:1986;57-78.
22. Glanville J.N. Post-mortem serum cholesterol levels. Br. Med. J. 2:1960;1852-1853.
23. Enticknap J.B. Lipids in cadaver sera after fatal heart attacks. J. Clin. Pathol. 14:1961;496-499.
24. Fekete J.F., Brunsdon D.F.V. The use of routine laboratory tests in postmortem examinations. Can. Soc. Forensic. Sci. 7:1974;238-254.
25. Hornick C.A., Baker H.N., Malcom G.T., Newman W.P., Roheim P.S., Strong J.P. Lipoproteins and apolipoproteins in postmortem serum. Modern Pathol. 1:1988;480-484.
26. Särkioja T., Ylä-Herttuala S., Solakivi T., Nikkari T., Hirvonen J. Stability of plasma total cholesterol, triglycerides, and apolipoproteins B and A-I during the early postmortem period. J. Forensic. Sci. 33:1988;1432-1438.
27. Freedman D.S., Wattigney W.A., Srinivasan S., Newman III W.P., Tracy R.E., Byers T., Berenson G.S. The relation of atherosclerotic lesions to antemortem and postmortem lipid levels: the Bogalusa Heart Study. Atherosclerosis. 104:1993;37-46.
28. Sekihara T., Nakano T., Nakajima K. High postprandial plasma remnant-like particles-cholesterol in patients with coronary artery diseases on chronic maintenance hemodialysis. Jpn. J. Nephrol. 38:1996;220-228.